News
EQRX
2.340
0.00%
0.000
Weekly Report: what happened at EQRX last week (0226-0301)?
Weekly Report · 03/04 10:31
Weekly Report: what happened at EQRX last week (0219-0223)?
Weekly Report · 02/26 10:39
Weekly Report: what happened at EQRX last week (0212-0216)?
Weekly Report · 02/19 10:41
Weekly Report: what happened at EQRX last week (0205-0209)?
Weekly Report · 02/12 10:33
Weekly Report: what happened at EQRX last week (0129-0202)?
Weekly Report · 02/05 10:39
Revolution Medicines Is Hard To Understand
Revolution Medicines, Inc. Has interesting science and early positive data. However, the company's market cap is too high for a company such as Revolution Medicines. The EQRx deal is highly interesting, but not enough to convince me to buy shares of RVMD.
Seeking Alpha · 02/01 21:02
Weekly Report: what happened at EQRX last week (0122-0126)?
Weekly Report · 01/29 10:32
Weekly Report: what happened at EQRX last week (0115-0119)?
Weekly Report · 01/22 10:35
Weekly Report: what happened at EQRX last week (0108-0112)?
Weekly Report · 01/15 10:32
Weekly Report: what happened at EQRX last week (0101-0105)?
Weekly Report · 01/08 10:35
Weekly Report: what happened at EQRX last week (1225-1229)?
Weekly Report · 01/01 10:31
Weekly Report: what happened at EQRX last week (1218-1222)?
Weekly Report · 12/25/2023 10:39
Weekly Report: what happened at EQRX last week (1211-1215)?
Weekly Report · 12/18/2023 10:43
Weekly Report: what happened at EQRX last week (1204-1208)?
Weekly Report · 12/11/2023 10:39
Weekly Report: what happened at EQRX last week (1127-1201)?
Weekly Report · 12/04/2023 10:39
Weekly Report: what happened at EQRX last week (1120-1124)?
Weekly Report · 11/27/2023 10:35
Weekly Report: what happened at EQRX last week (1113-1117)?
Weekly Report · 11/20/2023 10:33
SoftBank adds stakes in Neumora, Globalstar in Q3; stake in WeWork slashed
Softbank adds stakes in neumora, globalstar in q3; stake in wework slashed. Technology and investment firm exited eqrx and shift technologies in october. Softbank reduced stakes in signa sport and wework in the third quarter. Wework filed for chapter 11 bankruptcy on nov. 6.
Seeking Alpha · 11/14/2023 21:01
Weekly Report: what happened at EQRX last week (1106-1110)?
Weekly Report · 11/13/2023 10:28
Eqrx Inc: Current report
Press release · 11/10/2023 04:51
More
Webull provides a variety of real-time EQRX stock news. You can receive the latest news about Eqrx Inc through multiple platforms. This information may help you make smarter investment decisions.
About EQRX
EQRx, Inc. is a pharmaceutical company. The Company is engaged in developing medicines for some of the prevalent disease areas, including cancer and immune-inflammatory conditions. The Company brands include EQRx and Remaking Medicine. The Company's pipeline is comprised of approximately 10 programs, including both small molecules and biologics, with five clinical-stage programs, and several disclosed and undisclosed preclinical and drug engineering programs. Its clinical programs include Aumolertinib (EQ143), Lerociclib (EQ132), and Sugemalimab (EQ165). Aumolertinib (EQ143) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Lerociclib (EQ132) is a novel and oral small molecule cyclin-dependent kinase (CDK) 4/6 inhibitor. Sugemalimab (EQ165, also known as CS1001) is an anti-programmed cell death-ligand 1 (PD-L1) monoclonal antibody.